Home
News
Create
Screeners
Insights
Bal Pharma
79.
67
+0.72
(+0.91%)
Market Cap
₹126.84 Cr
PE Ratio
15.45
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+0.91%
1M
+11.58%
6M
-10.02%
1Y
-14.58%
5Y
+47.40%
View Company Insights
Latest news about Bal Pharma
Bal Pharma Q3FY26 Results: Net Profit Surges 181.84% YoY to ₹194.62 Lakhs
7 days ago
Bal Pharma Limited delivered outstanding Q3FY26 results with net profit jumping 181.84% year-on-year to ₹194.62 lakhs, while revenue from operations grew 20.03% to ₹8,749.48 lakhs. The company's Board of Directors approved the unaudited financial results during their meeting on February 11, 2026, with statutory auditors SSJNB & Co providing an unmodified opinion, demonstrating strong operational efficiency and regulatory compliance.
Bal Pharma Issues Postal Ballot Notice for Independent Director Appointment
Nov 12, 2025
Bal Pharma Defers Subsidiary Merger Decision, Citing Need for More Data
Nov 07, 2025
Bal Pharma Reports Q1 FY2026 Results, Approves Employee Stock Option Plan
Aug 11, 2025
Bal Pharma Schedules Board Meeting to Discuss Q1 Results, ESOP, and Subsidiary Merger
Jul 29, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation